Evidence map›Paper›PMID 41234823›Full record

ArticleTranslational cancer research2025

Prognostic significance of key immune cell functional alterations in clear cell renal cell carcinoma.

Yuhai Wu, Yantao Zhang, Ke Sun, Wenjie Niu, Yanhui Mei, Shimiao Zhu, Changyi Quan

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuhai WuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0009-0003-1706-0835
Yantao ZhangDepartment of Urology, Binzhou Medical University Hospital, Binzhou, China.
Ke SunDepartment of Urology, Binzhou Medical University Hospital, Binzhou, China.
Wenjie NiuDepartment of Urology, Binzhou Medical University Hospital, Binzhou, China.
Yanhui MeiDepartment of Urology, Binzhou Medical University Hospital, Binzhou, China.
Shimiao Zhu *Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Changyi Quan *Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While immune cells are pivotal in clear cell renal cell carcinoma (ccRCC), functional alterations of specific subsets and their prognostic implications remain unclear. We aimed to identify key immune cells, characterize their functional states, and develop a prognostic model by integrating single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing (RNA-seq) data. Methods: scRNA-seq dataset GSE210038 was analyzed to annotate tumor-infiltrating immune cells. Key immune cells were identified from deconvolved The Cancer Genome Atlas-Kidney Renal Clear Cell Carcinoma (TCGA-KIRC) and Gene Expression Omnibus Series (GSE)105261 datasets using support vector machine-recursive feature elimination (SVM-RFE), least absolute shrinkage and selection operator (LASSO), and random forest (RF) algorithms. Immune Response Enrichment Analysis (IREA) delineated polarization states of key immune cells in response to cytokines. Cellular communication was profiled via CellChat. Prognostic genes associated with key immune cells were screened by univariate Cox and LASSO regression. A risk score (RS) model was constructed and validated in TCGA-KIRC (training, n=511) and E-MTAB-1980 (validation, n=101) cohorts. Receiver operating characteristic (ROC) curves evaluated overall survival (OS) prediction efficacy. Nomograms and drug sensitivity analyses were performed. Results: Seven immune cell types infiltrated ccRCC. CD8 Conclusions: CD8+ T and NK cells exhibit functional polarization and altered cellular communication indicative of augmented anti-tumor immunity in ccRCC. The immune-cell-derived 10-gene signature provides a reliable prognostic tool and guides personalized therapy.

Indexed as

CD8+ T cellClear cell renal cell carcinoma (ccRCC)immune dictionarynatural killer cellprognostic model

Identifiers

PMID41234823
PMCPMC12611398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.